We set out to detect genes differentially expressed in prostate tumor and normal tissue specimens from BCR and non-BCR prostate cancer patients, and through their association with BCR status, to identify genes associated with favorable or adverse pathologic features. Here, BCR is linked to Familial prostate cancer.